ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,819Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 55

$625K Total Retail Price of All Prescriptions

Rank: 1 out of 55

450 Patients Receiving at Least One Drug in Part D
76% Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in District of Columbia
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

6% of this provider’s 450 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

10% of this provider’s 450 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in District of Columbia
LISINOPRIL 925 741 138 1 2
AMLODIPINE BESYLATE 662 481 98 2 1
FUROSEMIDE 621 488 102 3 5
HYDROCHLOROTHIAZIDE 553 434 91 4 9
SIMVASTATIN 510 382 69 5 7
ATORVASTATIN CALCIUM 388 298 65 6 3
NIFEDIPINE ER 295 277 39 7 22
METFORMIN HCL 295 231 49 7 15
METOPROLOL TARTRATE 262 208 48 9 13
CARVEDILOL 218 169 32 10 6
CLOPIDOGREL 213 191 33 11 8
METOPROLOL SUCCINATE 209 161 41 12 4
HYDRALAZINE HCL 188 148 33 13 14
CLONIDINE HCL 181 116 28 14 27
IBUPROFEN 179 130 42 15 29
OMEPRAZOLE 173 129 32 16 23
PROAIR HFA 164 142 42 17 35
POTASSIUM CHLORIDE 164 126 32 17 39
DIOVAN 148 104 21 19 16
GABAPENTIN 144 115 24 20 34
WARFARIN SODIUM 141 107 22 21 10
ATENOLOL 135 100 20 22 20
NEXIUM 120 101 23 23 30
SPIRIVA 119 114* 25 24 52
LOSARTAN POTASSIUM 117 96 20 25 11
RANITIDINE HCL 113 98 19 26 63
NAPROXEN 108 103* 29 27 51
LANTUS 107 65 20 28 66
COLCRYS 107 96 19 28 45
ACETAMINOPHEN-CODEINE 106 85 37 S3 30 18
NITROGLYCERIN PATCH 105 88 21 31 67
CRESTOR 99 94* 17 32 12
ZOLPIDEM TARTRATE 94 63 14 33 42
LISINOPRIL-HYDROCHLOROTHIAZIDE 94 71 13 33 20
TRIAMTERENE-HCTZ 89 70 14 35 35
DIGOX 88 88 14 36 53
RANEXA 86 81* 13 37 33
ADVAIR DISKUS 83 65 17 38 55
ALPRAZOLAM 83 44 14 B 38 49
KLOR-CON M10 76 63 18 40 50
SPIRONOLACTONE 74 47 11 41 19
MONTELUKAST SODIUM 67 62* 11 42 78
LEVOTHYROXINE SODIUM 67 62* 12 42 25
ALENDRONATE SODIUM 67 62* 11 42 60
LEVETIRACETAM 66 <11 <11 45 79
KLOR-CON M20 64 59* 13 46 59
VOLTAREN 64 59* 17 46 58
ISOSORBIDE MONONITRATE ER 64 <11 <11 46 17
LOSARTAN-HYDROCHLOROTHIAZIDE 62 <11 <11 49 26
PRAVASTATIN SODIUM 62 <11 <11 49 24
TAMSULOSIN HCL 62 48 12 49 47
ALLOPURINOL 58 <11 <11 52 62
BENICAR 56 <11 <11 53 65
PANTOPRAZOLE SODIUM 56 51* 12 53 39
GLIPIZIDE ER 55 <11 <11 55 86
VERAPAMIL ER 55 <11 <11 55 86
OXYCODONE-ACETAMINOPHEN 52 29 24 S2 57 32
GLIPIZIDE 51 <11 <11 58 38
GLIPIZIDE XL 51 <11 <11 58 94
ZETIA 51 <11 <11 58 41
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.